Temporal development of behavioral impairments in rats following locus coeruleus lesion induced by 6-hydroxydopamine: Involvement of β 3 -adrenergic receptors

• Published in: Neuropharmacology Vol. 151; p. 98
• Main Authors: Sampaio, Tuane Bazanella, Soares de Souza, Bruna, Roversi, Katiane, Schuh, Tayná, Poli, Anicleto, Takahashi, Reinaldo Naoto, Prediger, Rui Daniel
• Format: Journal Article
• Language: English
• Published: England 01-06-2019
• Subjects: Adrenergic Agents - toxicity; Adrenergic Neurons - drug effects; Animals; Behavior, Animal - drug effects; Discrimination, Psychological - drug effects; Disease Models, Animal; Locus Coeruleus - drug effects; Locus Coeruleus - metabolism; Male; Motor Activity - drug effects; Oxidopamine - toxicity; Rats; Rats, Wistar; Receptors, Adrenergic, beta-3 - metabolism; Recognition, Psychology - drug effects; Time Factors; 6-OHDA; Depression; Memory; Locus coeruleus; Olfaction; Apoptosis
• ISSN: 1873-7064
• DOI: 10.1016/j.neuropharm.2019.04.006

Noradrenergic degeneration in the locus coeruleus (LC) seems a convergent neuropathological marker of different neurodegenerative diseases. Herein, we investigated the temporal development of apoptotic signaling activation in the LC, noradrenergic dysfunction and behavioral impairments in rats following the noradrenergic lesion of the LC. For this purpose, the dopamine reuptake inhibitor nomifensine was administered 1 h before the stereotaxic bilateral injections of 6-hydroxydopamine (6-OHDA; 5, 10 or 20 μg/hem) into the LC. The behavioral and neurochemical analyses were performed at 7, 21 and 42 days after 6-OHDA injections. All doses of 6-OHDA induced neuronal death in LC, but only the highest dose (20 μg/hem) disrupted the motor function. 6-OHDA (5 μg/hem) injection induced short-term memory deficits in all periods, olfactory discrimination and long-term memory impairments at 7 days, and depressive-like behaviors at 21 and 42 days after injection. Moreover, 6-OHDA infusion increased Bax/Bcl2 ratio and caspase 3 levels, and decreased the dopamine β-hydroxylase immunocontent in the LC. Noradrenergic neurotransmission dysfunction was observed in the LC, olfactory bulb, prefrontal cortex, hippocampus and striatum. The intranasal (i.n.) noradrenaline (NA) infusion restored the impairments in the olfactory discrimination, short-term memory and depressive-like behavior of 6-OHDA-lesioned rats. In addition, these effects were blocked by the prior i.n. infusion of the β
-adrenergic receptor antagonist SR59230A. These findings indicate that the 6-OHDA injection into the LC induced the apoptosis signaling activation, noradrenergic neurotransmission dysfunction and behavioral impairments that were restored via β
-adrenergic receptors activation mediated by the i.n. NA administration.